Bulletin from the Meda AB (publ) extraordinary general meeting (EGM)

Today, Meda’s EGM unanimously approved the board’s decision to increase the company’s share capital by no more than SEK 23,220,968 to at most SEK 232,209,684. Consequently, at most 11,610,484 series A shares will be subscribed for within the new share issue. The new shares will be issued at a subscription price of SEK 160 per share. Shareholders have preferential rights to subscribe for one (1) new share for nine (9) old shares.

Important dates for the new share issue
Shares are listed ex-right to participation 11 January 2007
Record date for the right to participate 15 January 2007
Subscription period 19 January – 8 February 2007

A prospectus regarding the invitation to subscribe for shares in Meda AB (publ) in the 2007 share issue is held available on the company’s homepage, www.meda.se, and can also be received at:
• Meda AB, Pipers väg 2A, SE-170 09 Solna, Sweden, and
• SEB Enskilda, Skandinaviska Enskilda Banken AB, Kungsträdgårdsgatan 8, SE-106 40 Stockholm, Sweden

Solna, Sweden, 10 January 2007

The Board

About Us

Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy.


Documents & Links